Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comorbidity status does not independently predict survival outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Fairey AS, Jacobsen NE, Estey E, Tanguay S, Rendon R, Bell D, Izawa J, Chin J, Kapoor A, Matsumoto E, Black P, So A, Lattouf JB, Saad F, Drachenberg D, Cagiannos I, Lacombe L, Fradet Y, Kassouf W. Fairey AS, et al. Among authors: lattouf jb. Eur Urol. 2013 Sep;64(3):518-9. doi: 10.1016/j.eururo.2013.06.014. Epub 2013 Jun 19. Eur Urol. 2013. PMID: 23796500 No abstract available.
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial.
Motzer RJ, Russo P, Grünwald V, Tomita Y, Zurawski B, Parikh O, Buti S, Barthélémy P, Goh JC, Ye D, Lingua A, Lattouf JB, Albigès L, George S, Shuch B, Sosman J, Staehler M, Vázquez Estévez S, Simsek B, Spiridigliozzi J, Chudnovsky A, Bex A. Motzer RJ, et al. Among authors: lattouf jb. Lancet. 2023 Mar 11;401(10379):821-832. doi: 10.1016/S0140-6736(22)02574-0. Epub 2023 Feb 9. Lancet. 2023. PMID: 36774933 Free PMC article. Clinical Trial.
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial.
Motzer RJ, Russo P, Grünwald V, Tomita Y, Zurawski B, Parikh O, Buti S, Barthélémy P, Goh JC, Ye D, Lingua A, Lattouf JB, Albigès L, George S, Shuch B, Sosman J, Staehler M, Vázquez Estévez S, Simsek B, Spiridigliozzi J, Chudnovsky A, Bex A. Motzer RJ, et al. Among authors: lattouf jb. Target Oncol. 2023 Sep;18(5):639-641. doi: 10.1007/s11523-023-00987-1. Epub 2023 Sep 2. Target Oncol. 2023. PMID: 37659025 Free PMC article. Clinical Trial.
Preservation of bone health in prostate cancer.
Lattouf JB, Saad F. Lattouf JB, et al. Curr Opin Support Palliat Care. 2007 Oct;1(3):192-7. doi: 10.1097/SPC.0b013e3282f0c74f. Curr Opin Support Palliat Care. 2007. PMID: 18685362 Review.
The current management of small renal masses.
Trinh QD, Saad F, Lattouf JB. Trinh QD, et al. Among authors: lattouf jb. Curr Opin Support Palliat Care. 2009 Sep;3(3):180-5. doi: 10.1097/SPC.0b013e32832e9c6d. Curr Opin Support Palliat Care. 2009. PMID: 19553818 Review.
133 results